Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Davis

Showing results (341-350 of 391) with videos related to

Pageof 40
Sort By:
The Lancet. Oncology|August 29, 2014
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trialJ Athene Lane, Jenny L Donovan, Michael Davis, et al.
Nanomedicine (London, England)|October 18, 2022
Efficacy increase of lipid nanoparticles <i>in vivo</i> by inclusion of bis(monoacylglycerol)phosphateAmit Sagi, Rajesh Mukthavaram, River Recatto, et al.
Journal of Clinical Epidemiology|June 7, 2019
Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort studyJenny L Donovan, Brent Opmeer, Grace J Young, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 21, 2017
Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of GlaucomaElena Sánchez-López, Maria Antonia Egea, Benjamin Michael Davis, et al.
Cancer Causes & Control : CCC|April 25, 2012
A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United KingdomNicholas J Young, Chris Metcalfe, David Gunnell, et al.
Clinical Chemistry|November 22, 2012
Very low PSA concentrations and deletions of the KLK3 geneSantiago Rodriguez, Osama A Al-Ghamdi, Kimberley Burrows, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
A Multiomic Analysis to Identify Drivers of Subclinical Vascular Disease in Systemic Lupus ErythematosusChristopher Oliveira, Yenealem Temesgen-Oyelakin, Mohammad Naqi, et al.
Research Square|November 23, 2022
A C57BL/6 Mouse model of SARS-CoV-2 infection recapitulates age- and sex-based differences in human COVID-19 disease and recoveryMichael Davis, Kathleen Voss, J Bryan Turnbull, et al.
European Urology|March 24, 2009
Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohortsKate Tilling, Hans Garmo, Chris Metcalfe, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2010
Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancerSimon M Collin, Chris Metcalfe, Helga Refsum, et al.
Pageof 40

Showing results (341-350 of 391) with videos related to

Sort By:
Pageof 40
The Lancet. Oncology|August 29, 2014
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trialJ Athene Lane, Jenny L Donovan, Michael Davis, et al.
Nanomedicine (London, England)|October 18, 2022
Efficacy increase of lipid nanoparticles <i>in vivo</i> by inclusion of bis(monoacylglycerol)phosphateAmit Sagi, Rajesh Mukthavaram, River Recatto, et al.
Journal of Clinical Epidemiology|June 7, 2019
Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort studyJenny L Donovan, Brent Opmeer, Grace J Young, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 21, 2017
Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of GlaucomaElena Sánchez-López, Maria Antonia Egea, Benjamin Michael Davis, et al.
Cancer Causes & Control : CCC|April 25, 2012
A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United KingdomNicholas J Young, Chris Metcalfe, David Gunnell, et al.
Clinical Chemistry|November 22, 2012
Very low PSA concentrations and deletions of the KLK3 geneSantiago Rodriguez, Osama A Al-Ghamdi, Kimberley Burrows, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
A Multiomic Analysis to Identify Drivers of Subclinical Vascular Disease in Systemic Lupus ErythematosusChristopher Oliveira, Yenealem Temesgen-Oyelakin, Mohammad Naqi, et al.
Research Square|November 23, 2022
A C57BL/6 Mouse model of SARS-CoV-2 infection recapitulates age- and sex-based differences in human COVID-19 disease and recoveryMichael Davis, Kathleen Voss, J Bryan Turnbull, et al.
European Urology|March 24, 2009
Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohortsKate Tilling, Hans Garmo, Chris Metcalfe, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2010
Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancerSimon M Collin, Chris Metcalfe, Helga Refsum, et al.
Pageof 40